Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer

[1]  T. Ogihara,et al.  High-density association study and nomination of susceptibility genes for hypertension in the Japanese National Project. , 2007, Human molecular genetics.

[2]  Z. Luo,et al.  The E-cadherin gene polymorphism 160C->A and cancer risk: A HuGE review and meta-analysis of 26 case-control studies. , 2007, American journal of epidemiology.

[3]  K. Ogawa,et al.  GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-β-dependent apoptotic signalling , 2007, Oncogene.

[4]  C. Abnet,et al.  Interleukin-1B Polymorphisms and Gastric Cancer Risk—A Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[5]  T. Ochiya,et al.  Hedgehog signal activation in gastric pit cell and in diffuse-type gastric cancer. , 2006, Gastroenterology.

[6]  M. Inoue,et al.  Effect of Helicobacter pylori Infection Combined with CagA and Pepsinogen Status on Gastric Cancer Development among Japanese Men and Women: A Nested Case-Control Study , 2006, Cancer Epidemiology Biomarkers & Prevention.

[7]  E. El-Omar,et al.  Cellular and molecular aspects of gastric cancer. , 2006, World journal of gastroenterology.

[8]  Y. Kodera,et al.  Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry , 2006, Gastric Cancer.

[9]  P. Bejarano.  Differential Trends in the Intestinal and Diffuse Types of Gastric Carcinoma in the United States, 1973-2000: Increase in the Signet Ring Cell Type , 2006 .

[10]  Zhennan Gu,et al.  Anti-prostate stem cell antigen monoclonal antibody 1G8 induces cell death in vitro and inhibits tumor growth in vivo via a Fc-independent mechanism. , 2005, Cancer research.

[11]  N. Wright,et al.  Stem Cell Relationships and the Origin of Gastrointestinal Cancer , 2005, Oncology.

[12]  M. Daly,et al.  Genome-wide association studies for common diseases and complex traits , 2005, Nature Reviews Genetics.

[13]  Designing a multistage, SNP-based, genome screen for common diseases , 2004, Journal of Human Genetics.

[14]  Hong Nguyen,et al.  Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type. , 2004, Archives of pathology & laboratory medicine.

[15]  Mitsuru Sasako,et al.  Focus on gastric cancer. , 2004, Cancer cell.

[16]  F. Sharom,et al.  GPI-anchored protein cleavage in the regulation of transmembrane signals. , 2004, Sub-cellular biochemistry.

[17]  G. Satten,et al.  Inference on haplotype effects in case-control studies using unphased genotype data. , 2003, American journal of human genetics.

[18]  M. Stephens,et al.  Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. , 2003, Genetics.

[19]  C. P. Leblond,et al.  Defining Epithelial Cell Progenitors in the Human Oxyntic Mucosa , 2003, Stem cells.

[20]  G. Snow,et al.  Characterization of the human Ly‐6 antigens, the newly annotated member Ly‐6K included, as molecular markers for head‐and‐neck squamous cell carcinoma , 2003, International journal of cancer.

[21]  Teruhiko Yoshida,et al.  Outline of disease gene hunting approaches in the Millennium Genome Project of Japan , 2003 .

[22]  D. Roder,et al.  The epidemiology of gastric cancer , 2002, Gastric Cancer.

[23]  R. Reiter,et al.  Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells. , 2002, Molecular cancer research : MCR.

[24]  T. Merriman,et al.  Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer , 2002, Oncogene.

[25]  Yusuke Nakamura,et al.  Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190 562 genetic variations in the human genome , 2002, Journal of Human Genetics.

[26]  C. Caldas,et al.  CDH1 c‐160a promotor polymorphism is not associated with risk of stomach cancer , 2002, International journal of cancer.

[27]  Xiaofeng Zhu,et al.  Association mapping, using a mixture model for complex traits , 2002, Genetic epidemiology.

[28]  G. Capellá,et al.  Genetic susceptibility and gastric cancer risk , 2002, International journal of cancer.

[29]  Douglas F. Easton,et al.  Polygenic susceptibility to breast cancer and implications for prevention , 2002, Nature Genetics.

[30]  Yusuke Nakamura,et al.  JSNP: a database of common gene variations in the Japanese population , 2002, Nucleic Acids Res..

[31]  Yusuke Nakamura,et al.  A high-throughput SNP typing system for genome-wide association studies , 2001, Journal of Human Genetics.

[32]  A. Ochiai,et al.  Histologic heterogeneity and mucin phenotypic expression in early gastric cancer , 2001, Pathology international.

[33]  R. Hubert,et al.  Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G. Jakse,et al.  Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors. , 2000, Biochemical and biophysical research communications.

[35]  J. Kaprio,et al.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.

[36]  K. Roeder,et al.  The power of genomic control. , 2000, American journal of human genetics.

[37]  M. Loda,et al.  Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer , 2000, Oncogene.

[38]  T. Saito,et al.  Borrmann's type IV gastric cancer: clinicopathologic analysis. , 1999, Canadian journal of surgery. Journal canadien de chirurgie.

[39]  J. Yokota,et al.  Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. , 1999, Carcinogenesis.

[40]  G. Berx,et al.  E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[41]  M. Loda,et al.  Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[42]  S. Hirohashi,et al.  Modified formalin and methanol fixation methods for molecular biological and morphological analyses , 1997, Pathology international.

[43]  H. Espejo,et al.  [Gastric cancer]. , 1996, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.

[44]  C. P. Leblond,et al.  Origin and migratory pathways of the eleven epithelial cell types present in the body of the mouse stomach , 1995, Microscopy research and technique.

[45]  胃癌研究会.  Japanese classification of gastric carcinoma , 1995 .

[46]  P. Correa,et al.  Phenotypic and genotypic events in gastric carcinogenesis. , 1994, Cancer research.

[47]  P. Laurén,et al.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.

[48]  Iels,et al.  Analyses of Cohorts of Twins from Sweden , Denmark , and Finland , 2022 .